DNDi and Cipla advance development of pediatric 4-in-1 ARVs to fulfill new WHO guidelines

The World Health Organization’s new HIV treatment guidelines, released today at the 2013 International AIDS Society Conference, include new antiretroviral therapy recommendations for HIV-infected children, and will mean that more children will be on better treatments. The Drugs for Neglected Diseases initiative applauds the new guidelines and, with Cipla Ltd. and other partners, is expediting the development of urgently needed 4-in-1 ARVs adapted for babies and toddlers with HIV, to be delivered…

Fuente : http://www.eurekalert.org/pub_releases/2013-06/dfn…